Atomic AI

Accelerate RNA drug discovery using a foundation model that predicts 3D structures with atomic precision to unlock previously inaccessible therapeutic targets.

Paid only

Price not published

About Atomic AI

Atomic AI is a cutting-edge biotechnology company specializing in the fusion of machine learning and structural biology to transform the landscape of RNA-centric medicine. The company focuses on the discovery and design of RNA-targeted small molecules as well as RNA-based therapeutics. By utilizing their sophisticated proprietary foundation model, ATOM-1, the organization aims to overcome significant historical barriers in drug discovery. This model provides a high-resolution, three-dimensional understanding of RNA structures, allowing for the exploration of targets that were previously considered impossible to reach with standard medicinal chemistry. The technical core of Atomic AI lies in its integrated R&D platform, which creates a virtuous cycle between computational innovation and experimental validation. The system utilizes state-of-the-art deep learning models that are continuously fed data from purpose-built, in-house wet-lab assays. This synergy ensures that the AI’s structural predictions are not just theoretical but are grounded in biological reality. The platform enables researchers to identify specific binding pockets and complex structural motifs within RNA, effectively expanding the therapeutic toolkit to include undruggable targets associated with a wide variety of human diseases. This sophisticated tool is primarily intended for biopharmaceutical companies, research scientists, and drug discovery teams who are focused on the next generation of therapeutic interventions. It is particularly well-suited for roles in medicinal chemistry and computational biology where understanding the intricacies of RNA folding is critical. Use cases range from early-stage target identification to the optimization of lead compounds. By shifting the focus from proteins to RNA, users of this technology can pioneer new treatments for oncology, rare genetic disorders, and complex infectious diseases that do not respond to traditional protein-targeting methods. What distinguishes Atomic AI from its competitors is its absolute focus on atomic precision within the specialized field of RNA structural biology. While many other AI platforms in the biotech space prioritize protein folding or general molecular docking, Atomic AI’s ATOM-1 model is uniquely architecture-tailored to the specific chemical and physical properties of RNA sequences. Supported by a world-class interdisciplinary team and a board of scientific advisors from institutions like Stanford and UC San Diego, the company provides a level of specialized expertise and verified predictive power that sets a new standard for RNA-focused drug discovery.

Atomic AI pros & cons

Pros

Predicts 3D RNA structures with atomic-level precision using the ATOM-1 model.
Combines computational AI with in-house wet-lab validation for higher accuracy.
Enables the targeting of undruggable RNA sequences that traditional methods miss.
Led by a team that includes a drug hunter who advanced 33 clinical candidates.
Focuses specifically on RNA, a rapidly growing and specialized area of therapeutic interest.

Cons

No self-service or public-facing trial version is available for individual researchers.
Requires custom partnership agreements to access the core platform technology.
Specialized focus on RNA means it is not applicable for protein-only research projects.

Atomic AI use cases

Pharmaceutical researchers can use ATOM-1 to identify novel binding sites on RNA molecules for small-molecule drug development.
Biotechnology firms can accelerate the design of RNA-based therapeutics by predicting the stability and folding of custom RNA sequences.
Medicinal chemists can leverage the platform's 3D structural insights to optimize the potency and selectivity of lead compounds targeting RNA.

Atomic AI features

interdisciplinary ml-bio workflow
proprietary structural biology data
rna-based therapeutic discovery
rna-targeted small molecule design
deep learning r&d platform
integrated wet-lab assays
3d rna structure prediction
atom-1 foundation model

Atomic AI pricing

Is Atomic AI free? No, Atomic AI doesn't offer a free plan.

Custom Partnership

Price varies

Access to ATOM-1 foundation model
3D RNA structure prediction
Collaborative wet-lab validation
Small molecule design support
RNA-based therapeutic development
Direct access to interdisciplinary ML-Bio experts

Atomic AI FAQs

What is the ATOM-1 foundation model?

ATOM-1 is Atomic AI's proprietary deep learning model designed to predict the three-dimensional structure of RNA with atomic precision. It allows researchers to visualize and target previously inaccessible RNA structures for drug development.

How does Atomic AI integrate wet-lab data with machine learning?

The platform operates in a virtuous cycle where purpose-built, in-house wet-lab assays provide real-world data to train and refine deep learning models. This ensures that the AI's predictions are constantly validated and improved by experimental results.

What types of medicines can be developed using this platform?

The technology supports the discovery of both RNA-targeted small molecules and RNA-based therapeutics. This versatility allows for multiple approaches to treating diseases by interacting with RNA at different stages.

Who is the primary target audience for the Atomic AI platform?

The platform is intended for biopharmaceutical companies and research institutions looking to advance their RNA drug discovery pipelines. It is especially valuable for targeting diseases that are difficult to treat with traditional protein-centric therapies.

Open roles

All AI jobs

Atomic AI

Data Scientist, RNA Biology

science hybrid South San Francisco, US$135,000/year - $180,000/year full-time

Benefits:

equity
benefits

Education Requirements:

Ph.D. in Computational Biology, Bioinformatics, Statistics, Biophysics, or related field, or equivalent experience

Experience Requirements:

Expertise in RNA biology and biochemistry, RNA-protein interactions, and RNA structure
Proficiency in Python for data curation and analysis at scale
Strong programming background, familiarity with Unix
Strong foundation in statistics and experience with conducting statistical analysis of large-scale datasets

Other Requirements:

Authorized to work lawfully in the US
Open to working in-person at South San Francisco several days a week

Responsibilities:

Provide RNA biology and RNA structure expertise on the ML team
Enable and apply RNA-structure platform to prioritize RNA targets
Generate insights from datasets on RNA structures and small molecule interactions
Curate RNA datasets for training of ML models
Inform scientific questions and ML model development

Show more details

Ratings & reviews

No reviews yet. Be the first to share how Atomic AI worked for you.